An open label randomized clinical trial to evaluate the add on effects of deepana - pachana yoga in the management of Naveen avastha of amavata with special reference to rheumatoid arthritis.

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients with pratyatma lakshana of Amavata (e.g. Angamarda, shotha, sandhishool, stabhata, Trishna, Alasye, Aruchi, gaurava, jawara, apaka sparshaasahata) specially with impaired jatharagani and dhatuagani.
•2. The 2010 American College of Rheumtology/ European League Against Rheumatism.
•3. Able and willing to give written informed consent.

•1. Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â??pericardial disease.
•2. Patients with poorly controlled Hypertension ( >160/100 mm of Hg).
•3. Patients with Diabetes Mellitus {B.S. (F) > 126 mg% and / or B.S. (2 hr. PP) >200 mg% OR HbA1c > 6.5%}
•4. Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc.
•5. Patients who are unable to walk without support and / or confined to wheel chair.
•6. Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study.
•7. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•8. Patients with concurrent serious hepatic disorder or Renal Disorders. Severe Pulmonary Dysfunction or any other condition that may jeopardize the study.
•9. H/o hypersensitivity to any of the trial drugs or their ingredients.
•10. Pregnant / lactating woman.
•11. Patients who have completed participation in any other clinical trial during the past 6 months.

发起方